Siliq 210 mg/1 (Brodalumab INJECTION) 210 mg/1

Siliq 210 mg/1 is a subcutaneous injection containing Brodalumab, used for managing moderate to severe plaque psoriasis. This medication is designed to help reduce skin inflammation and improve skin appearance.

Strength

210 mg/1

Pack Size

2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00)

Manufacturer / TM Owner

Bausch Health US LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Siliq 210 mg/1 is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Brodalumab, the active ingredient, works by targeting specific proteins involved in the inflammatory process. People often ask, 'What is Siliq used for?' and the answer is that it is intended for those who have not responded well to other treatments.

Side Effects

Common effects of Siliq 210 mg/1 may include redness, itching, or swelling at the injection site. Some individuals might experience fatigue, headache, or joint pain. These effects vary and are not experienced by everyone.

Precautions & Warnings

Siliq 210 mg/1 should be handled with care. It is important to follow the prescribed administration guidelines and store the medication properly. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

Siliq 210 mg/1 may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.

References

Frequently Asked Questions

Siliq is used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Siliq is administered as a subcutaneous injection, typically self-administered after proper training.

Common side effects may include redness, itching, or swelling at the injection site, fatigue, headache, or joint pain.

Siliq may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Siliq should be stored according to the manufacturer's guidelines to maintain its effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.